✦ LIBER ✦

Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate

✍ Scribed by Ju-Yoon Yoon; Rajat Kumar; Raquel Aloyz; James B. Johnston

Book ID: 113773475
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 162 KB
Volume: 35
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2011.06.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Familial adenomatous polyposis complicat

Familial adenomatous polyposis complicated by chronic myelogenous leukemia: response to imatinib mesylate

✍ Takeyoshi Itsukuma; Hideki Ishikawa; Mahito Misawa; Shunro Kai; Yoshihiro Fujimo 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 278 KB

Imatinib Mesylate in the Treatment of Ch

Imatinib Mesylate in the Treatment of Chronic Myelogenous Leukemia

✍ Gautam Borthakur; Jorge E. Cortes 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 108 KB

Imatinib Mesylate: : A New Pill for Chro

Imatinib Mesylate: : A New Pill for Chronic Myelogenous Leukemia

✍ Kavita K. Parmar; Reginald S. King 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Coexistence of chronic myelogenous leuke

Coexistence of chronic myelogenous leukemia and chronic lymphocytic leukemia

✍ Zwi A. Schreiber; Morton R. Axelrod; Lool S. Abebe 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Cardiac tamponade associated with imatin

Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia

✍ James C. Barton; Steven C. Jones; Wade C. Lamberth; Michael T. Reymann; Varian C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

Persistent neutropenia in chronic myelog

Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate

✍ Yu-Yan Hwang; Eric Tse; Jason C.C. So; Thomas S.K. Wan; Yok-Lam Kwong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

A physician or a group of physicians considers presentation and evolution of a real clinical case, reacting to clinical information and data (boldface type). This is followed by a discussion/commentary.